| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 85 |
| 1 | OCTREOTIDE ACETATE | 44 |
| 2 | OMEPRAZOLE MAGNESIUM | 43 |
| 3 | ASPIRIN | 38 |
| 4 | ASPIRIN 325 MG | 38 |
| 5 | ASPIRIN 81 MG | 38 |
| 6 | INFLIXIMAB | 38 |
| 7 | OMEPRAZOLE | 35 |
| 8 | FUROSEMIDE | 34 |
| 9 | PANTOPRAZOLE | 34 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEPIVACAINE HYDROCHLORIDE | 9 | 0.0078 |
| 1 | SODIUM CARBONATE | 1 | 0.0043 |
| 2 | PANTHENOL | 1 | 0.0034 |
| 3 | VERAPAMIL HYDROCHLORIDE | 12 | 0.0028 |
| 4 | TEBENTAFUSP | 1 | 0.0017 |
| 5 | OCTREOTIDE ACETATE | 44 | 0.0014 |
| 6 | PIROXICAM | 9 | 0.0014 |
| 7 | MIRVETUXIMAB SORAVTANSINE | 2 | 0.0011 |
| 8 | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | 1 | 0.0011 |
| 9 | MOSUNETUZUMAB | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 83 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 74 |
| 2 | Corticosteroid [EPC] | 65 |
| 3 | Proton Pump Inhibitor [EPC] | 53 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 41 |
| 5 | Benzodiazepine [EPC] | 41 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 39 |
| 7 | Loop Diuretic [EPC] | 37 |
| 8 | Factor Xa Inhibitor [EPC] | 33 |
| 9 | Kinase Inhibitor [EPC] | 26 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 2 | Somatostatin Analog [EPC] | 5 | 0.0007 |
| 3 | beta Lactamase Inhibitor [EPC] | 2 | 0.0004 |
| 4 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 5 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 6 | Photoenhancer [EPC] | 1 | 0.0003 |
| 7 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 8 | Integrin Receptor Antagonist [EPC] | 20 | 0.0002 |
| 9 | GLP-2 Analog [EPC] | 3 | 0.0002 |